Back to calendar
Larimar Therapeutics, Inc. (LRMR) Earnings
LRMR reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.35
Actual EPS: $-0.30
EPS surprise: 21.35%
Company overview
Market Cap$416.6M
PriceUSD 4.01
EPS (TTM)-1.98
52-week high6.42
52-week low2.71
SectorHealth Technology
IndustryBiotechnology
Employees71